tirzepatide weight loss florida What Is for Loss? Medical Weight Loss Injections in

Clinical trials show up to ~24% body weight reduction over 48 weeks at higher doses

GLP-1s need refrigeration before first use

Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc

J., Bajaj, M., Bannuru, R

Brain tissue : May support neuronal regeneration, offering neuroprotective effects

Your provider will individualize this based on your tolerance, side effect history, and how much weight you still want to lose